Literature DB >> 10486432

Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm.

H Okuyama1, Y Ikeda, S Kasai, K Imamori, K Takayama, T Nagai.   

Abstract

The influence of pH in the formulation, ethylene oxide chain length of polyoxyethylene (POE) non-ionic surfactants and addition of propylene glycol (PG) on percutaneous absorption of piroxicam (Px) from cataplasm was investigated in guinea-pig in vivo. The area under the plasma concentration of Px curve until 8 h after the application (AUC(0-8)) increased with increasing the cataplasm base pH up to 6.5 and then plateaued from pH 6.5 to 7.2. Px solubility in water increased markedly with increasing pH from pH 6 as Px is a weak acid and its pK(a) is 5.3. The ionic form of Px in the cataplasm was suspected to contribute to the percutaneous absorption of Px. The percutaneous absorption of Px from the cataplasms containing 5% of POE non-ionic surfactants with various POE lengths were examined. The parabolic relation between the Px absorption and the POE length was observed. POE length from 5 to 15 enhanced percutaneous absorption to a greater extent. An attempt was also made to examine the influence of the addition of PG to the formulation containing POE (9) lauryl ether. The addition of 20% PG to the formulation significantly increased the Px concentration in plasma, compared to 0, 5, 10 and 15% PG. Skin and cutaneous muscle concentrations significantly increased by addition of 20% PG, compared to those by 0% PG but not in deeper muscle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486432     DOI: 10.1016/s0378-5173(99)00154-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Cocrystal Solubility Product Prediction Using an in combo Model and Simulations to Improve Design of Experiments.

Authors:  Alex Avdeef
Journal:  Pharm Res       Date:  2018-02-02       Impact factor: 4.200

2.  Topical piroxicam in vitro release and in vivo anti-inflammatory and analgesic effects from palm oil esters-based nanocream.

Authors:  Muthanna F Abdulkarim; Ghassan Z Abdullah; Mallikarjun Chitneni; Ibrahim M Salman; Omar Z Ameer; Mun F Yam; Elrashid S Mahdi; Munavvar A Sattar; Mahiran Basri; Azmin M Noor
Journal:  Int J Nanomedicine       Date:  2010-11-04

3.  In vitro permeation and in vivo anti-inflammatory and analgesic properties of nanoscaled emulsions containing ibuprofen for topical delivery.

Authors:  Ghassan Z Abdullah; Muthanna F Abdulkarim; Ibrahim M Salman; Omar Z Ameer; Mun F Yam; Ahmed F Mutee; Mallikarjun Chitneni; Elrashid S Mahdi; Mahiran Basri; Munavvar A Sattar; Azmin M Noor
Journal:  Int J Nanomedicine       Date:  2011-02-17

4.  Status of surfactants as penetration enhancers in transdermal drug delivery.

Authors:  Iti Som; Kashish Bhatia; Mohd Yasir
Journal:  J Pharm Bioallied Sci       Date:  2012-01

5.  Compound antimalarial ethosomal cataplasm: preparation, evaluation, and mechanism of penetration enhancement.

Authors:  Shuo Shen; Shu-Zhi Liu; Yu-Shi Zhang; Mao-Bo Du; Ai-Hua Liang; Li-Hua Song; Zu-Guang Ye
Journal:  Int J Nanomedicine       Date:  2015-06-30

6.  Effects of various penetration enhancers on percutaneous absorption of piroxicam from emulgels.

Authors:  J Shokri; Sh Azarmi; Z Fasihi; S Hallaj-Nezhadi; A Nokhodchi; Y Javadzadeh
Journal:  Res Pharm Sci       Date:  2012-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.